Literature DB >> 10066963

Hyperimmunoglobin E syndrome: a sign of TH1/TH2 imbalance?

Y Shirafuji1, H Matsuura, A Sato, H Kanzaki, H Katayama, J Arata.   

Abstract

We report on a patient with hyperimmunoglobulin E syndrome, who developed pruritic vesiculopapules from the age of six months and also had recurrent episodes of skin abscesses and oral thrush. Serum IgE was extremely elevated at 59,514 IU/ml and specific IgE antibody to Staphylococcus aureus was positive. Histological examination from a vesiculopapule on the face revealed that eosinophil-rich infiltration involved hair follicles, similar to eosinophilic pustular folliculitis. We also examined cytokine profiles of circulating CD4+ T cells by intracellular cytokine staining and flow cytometry. The ratio of cells positive for interferon-gamma was significantly reduced compared with a control. Several reports have shown decreased interferon-gamma production by peripheral blood mononuclear cells of patients with hyperimmunoglobulin E syndrome. We think that this cytokine profile and the histological findings of our patient support the hypothesis that TH1/TH2 imbalance is involved in hyperimmunoglobulin E syndrome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10066963

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  2 in total

1.  Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency.

Authors:  F L van de Veerdonk; R J Marijnissen; R Marijnissen; L A B Joosten; B J Kullberg; J P H Drenth; M G Netea; J W M van der Meer
Journal:  Clin Exp Immunol       Date:  2009-10-30       Impact factor: 4.330

Review 2.  The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.

Authors:  Aleksandra Szczawinska-Poplonyk; Zdzislawa Kycler; Barbara Pietrucha; Edyta Heropolitanska-Pliszka; Anna Breborowicz; Karolina Gerreth
Journal:  Orphanet J Rare Dis       Date:  2011-11-15       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.